Jones Mitchell Lawrence, Chief Medical Officer of Palisade Bio, Inc. ($PALI), sold shares on the open market once in the last year for a total of $3,481. His most recent sale occurred on February 12, 2026. These sales rank 11,448th among 11,678 insiders, well below the average of $8.6 million across about 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 8000 | $0.00 | 16,000.0000 | 149,003,210 | 33.33% | 0.01% |
| Feb. 12, 2026 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | S | Common Stock | 1989 | $1.75 | 13,263.0000 | 149,003,210 | 13.04% | 0.00% |
| Feb. 11, 2026 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock | 8000 | $0.00 | 15,252.0000 | 149,003,210 | 110.31% | 0.01% |
| Feb. 9, 2026 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 787000 | $0.00 | 787,000.0000 | 149,003,210 | 9999.99% | 0.53% |
| Oct. 6, 2025 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 7665800 | $0.00 | 7,665,800.0000 | 4,396,646 | 9999.99% | 100.00% |
| Sept. 4, 2025 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Phantom Units | 289000 | $0.00 | 289,000.0000 | 4,396,646 | 9999.99% | 6.57% |
| Feb. 11, 2025 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Stock Option (Right to Buy) | 29000 | $0.00 | 29,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 2735 | $0.00 | 3,568.0000 | 0 | 328.33% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 1555 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 2735 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 461 | $4.76 | 3,852.0000 | 0 | 10.69% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 1555 | $0.00 | 4,313.0000 | 0 | 56.38% | 0.00% |
| May 28, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 810 | $4.76 | 2,758.0000 | 0 | 22.70% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | M | Common Stock, par value $0.01 | 304 | $0.00 | 814.0000 | 0 | 59.61% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | M | Restricted Stock Units | 304 | $0.00 | 2,735.0000 | 0 | 10.00% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | F | Common Stock, par value $0.01 | 47 | $8.46 | 833.0000 | 0 | 5.34% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | M | Common Stock, par value $0.01 | 156 | $0.00 | 880.0000 | 0 | 21.55% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | F | Common Stock, par value $0.01 | 90 | $8.46 | 724.0000 | 0 | 11.06% | 0.00% |
| May 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | CEO, CFO, Director | M | Restricted Stock Units | 156 | $0.00 | 1,555.0000 | 0 | 9.12% | 0.00% |
| Feb. 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 4558 | $0.00 | 7,482.0000 | 0 | 155.88% | 0.00% |
| Feb. 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 2333 | $0.00 | 9,815.0000 | 0 | 31.18% | 0.00% |
| Feb. 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 2153 | $0.44 | 7,662.0000 | 0 | 21.94% | 0.00% |
| Feb. 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 4558 | $0.00 | 45,586.0000 | 0 | 9.09% | 0.00% |
| Feb. 6, 2024 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 2333 | $0.00 | 25,667.0000 | 0 | 8.33% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Common Stock Options | 33160 | $0.00 | 33,160.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | A | Restricted Stock Units | 28000 | $0.00 | 28,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2023 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | F | Common Stock, par value $0.01 | 1630 | $0.54 | 2,926.0000 | 0 | 35.78% | 0.00% |
| Nov. 6, 2023 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Common Stock, par value $0.01 | 4556 | $0.00 | 4,556.0000 | 0 | 9999.99% | 0.00% |
| Nov. 6, 2023 | PALISADE BIO, INC. | $PALI | Jones Mitchell Lawrence | Chief Medical Officer | M | Restricted Stock Units | 4556 | $0.00 | 50,144.0000 | 0 | 8.33% | 0.00% |